Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus

Journal of Perinatology

Volumn 27, Issue 12, 2007, Pages 744-748

  Chasnoff, I J ^a   Wells, A M ^a   McGourty, R F ^a   Bailey, L K ^a  

^a Children's Research Triangle   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

4P PLUS; ADULT; ALCOHOL ABUSE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; FEMALE; FOLLOW UP; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; PREDICTIVE VALIDITY; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; RELIABILITY; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; VALIDATION PROCESS;

ADULT; ALCOHOLIC BEVERAGES; FEMALE; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREGNANCY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 36549089079     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211823     Document Type: Article

References (29)

1. Lester BM, Corwin MJ, Sepkoski C, Seifer R, Peucher M, McLaughlin S et al. Neurobehavioral syndromes in cocaine-exposed newborn infants. Child Dev 1991; 62: 694-705.
2. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy. J Am Med Assoc 1989; 741-1744.
3. Finnegan LP, Connaughton JF, Kron RE, Samuels SJ, Batra KK. Neonatal abstinence syndrome: Assessment and management. In: Harbison RD (ed). Perinatal Addiction. Spectrum Publications: New York, 1975 pp 141-158.
4. Streissguth AP, Sampson P, Barr H. Neurobehavioral dose-response effects of prenatal alcohol exposure in humans from infancy to adulthood. Ann NY Acad Sci 1989; 562: 145-158.
5. Fried PA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr 1990; 11(2): 49-58.
6. American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. ACOG Technical Bulletin No. 195. American College of Obstetricians and Gynecologists: Washington (DC), 1994.
7. Perl HI. Numerous Studies Demonstrate Effecftiveness of Brief Interventions. NIAAA: Frontlines Washington DC, 2000.
8. US preventive services task force ratings: Strength of recommendations and quality of evidence. Guide to Clinical Preventive Services, Third Edition: Periodic Updates 2000-2003. Agency for Healthcare Research and Quality: Rockville, MD http://www.ahrq.gov/clinic/3rduspstf/ ratings.htm.
9. Chasnoff IJ, Neuman K, Thornton C, Callaghan MA. Screening for substance use in pregnancy: A practical approach for the primary care physician. Am J Obstet Gynecol 2001; 184: 752-758.
10. Ewing J. Detecting alcoholism: The CAGE questionnaire. JAMA 1984; 252: 1905-1907.
11. Kitchens JM. Does this patient have an alcohol problem? JAMA 1994; 272: 1782-1787.
12. Bottoms SF, Martier SS, Sokol RJ. Refinements in screening for risk drinking in reproductive-aged women: The 'NET' results. Alcohol Clin Exp Res 1989; 13: 339.
13. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: Practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989; 160: 863-868.
14. Russsell M, Martier SS, Sokol RJ, Mudar P, Bottoms S, Jacobson S et al. Screening for pregnancy risk-drinking: TWEAKing the tests. Alcohol Clin Exp Res 1991; 15: 368 abstract no. 338.
15. Chan AW, Pristach EA, Welte JW, Russell M. Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations. Alcohol Clin Exp Res 1993; 17: 1188-1192.
16. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Arch Intern Med 1998; 158: 1789-1795.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV: International Version with ICD-10 Codes 1995.
18. Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T et al. Prenatal alcohol exposure and childhood behavior at age 6-7 years: I. Dose - response effect. Pediatrics 2001; 108: e34.
19. Chasnoff IJ, Hung WC. The 4P's Plus. NTI Publishing; Chicago, 1999.
20. Chasnoff IJ, McGourty RF, Bailey GF, Hutchins E, Lightfoot SO, Pawson LL et al. The 4P's Plus#© screen for substance use in pregnancy: Clinical application and outcomes. J Perinatol 2005; 368-374.
21. Hutchins E, DiPietro J. Psychosocial risk factors associated with cocaine use during pregnancy: A case - control study. Obstet Gynecol 1997; 90: 142-147.
22. Center for Substance Abuse Prevention. Maternal Substance Use Assessment Methods Reference Manual: A Review of Screening and Clinical Assessment Instruments for Examining Maternal Use of Alcohol, Tobacco, and Other Drugs, (DHHS Publication no. (SMA) 93-2059) Division of Communication Programs: Rockville, MD, 1993.
23. Larrson G. Prevention of fetal alcohol effects: An antenatal program for early detection of pregnancies at risk. Acta Obstet Gynecol Scand 1983; 62: 171-178.
24. Little RE, Young A, Streissguth AP, Uhl CN. Preventing fetal alcohol effects: Effectiveness of a demonstration project In: CIBA Foundation Symposium 105, Mechanisms of Alcohol Damage In Utero. Pitman Press: London, 1984 pp 254-274.
25. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy: Perinatal outcome. JAMA 1989; 261: 1741-1744.
26. Armstrong MA, Osejo VG, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol 2003; 23: 3-9.
27. Huizink AC, Mulder EJH. Maternal smoking, drinking, or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Behav Rev 2006; 30: 24-41.
28. Roche AM, Richard GP. Doctors' willingness to intervene in patients' drug and alcohol problems. Soc Sci Med 1991; 33: 1053-1061.
29. ACOG Committee on Ethics. At-risk drinking and illicit drug use: Ethical issues in obstetric and gynecologic practice. ACOG Committee Opinion No. 294. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004; 103: 1021-1031.